FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma

Figure 10  Expression and receiver operating characteristic curve validation of the The Gene Expression Omnibus dataset for prognosis-related differentially expressed genes. A: Expression validation plot of gene FDX1, LIAS, MTF1 in data set GSE26942; B: Expression validation plot of gene FDX1, LIAS, MTF1 in data set GSE54129; C: Expression validation plot of gene FDX1, LIAS, MTF1 in data set GSE66229; D: Expression validation plot of gene FDX1, LIAS, MTF1 in data set The Cancer Genome Atlas (TCGA)-stomach adenocarcinoma (STAD). MTF1 expression validation plot in dataset TCGA-STAD; E: Receiver operating characteristic curves (ROCs) for gene FDX1, LIAS, MTF1 in dataset GSE26942; F: ROC validation of gene FDX1, LIAS, MTF1 in dataset GSE54129; G: ROC curves for gene FDX1, LIAS, MTF1 in dataset ROC validation in dataset GSE66229; H: ROC validation of gene FDX1, LIAS, MTF1 in dataset TCGA-STAD; I: ROC validation of gene FDX1, LIAS, MTF1 in dataset TCGA-STAD. Up: Up-regulated genes; Down: Down-regulated genes; AUC: Aera under the curve. ¹P < 0.01, which is highly statistically significant. ²P < 0.001 and highly statistically significant.